HOME / NEWS & PERSPECTIVES / Corporate

News, stories & opinions for the world’s healthtech innovators.

Corporate

PI acquires BIT Group’s North American operations, doubling its medtech manufacturing capacity

Based in Irvine, California, the addition of BIT Group’s 29,000 sq. ft. facility solidifies PI’s commitment to grow its manufacturing capabilities to support its growing U.S. customer base.

SOPHIE THOMAS

Posted November 2021

in MANUFACTURING

Markets.

Diagnostics

Life Sciences

Cell & Gene Therapy

Medical Devices

Topics.

Opinion

Commercialization

Awards

Digital Health

Point-of-Care

Ventures

Corporate

Software

COVID-19

People & Culture

Entrepreneurship

Innovation

Fertility

Lumos Diagnostics

Energy

Manufacturing

Sign up for the Perspectives newsletter:

Planet Innovation’s unique ‘strategic investor’ approach proves a winner

Planet Innovation is redefining what it means to be a strategic investor by providing investee companies with not just funding, but access to its people, facilities and networks.

Lumos Chair Sam Lanyon and CTO Sacha Dopheide ring the bell to list on the ASX.

Lumos Diagnostics raises A$63m in ASX IPO

Lumos Diagnostics, a PI investee company, has been admitted to the Australian Securities Exchange (ASX) with trading commencing on July 5 after raising $63 million AUD in an Initial Public Offering (IPO).

Grid of six photos showing different ways of working at PI

How PI is giving staff the freedom to match their work style to their lifestyle

At PI, we believe that work is ‘what we do’ not ‘where we go’. That's why we've introduced new Ways of Working that empower our people to choose where, when and how they work to produce their best outcomes.

PM Scott Morrison and Gladys Liu MP meets Planet Innovation CEOs Stuart Elliott and Sam Lanyon

Prime Minister Scott Morrison congratulates PI on its “tremendous success” during tour of expanded facility

Prime Minister Scott Morrison and Federal Member for Chisholm Gladys Liu visited Planet Innovation to tour our expanded manufacturing and design facilities, and discuss the recently announced Patent Box tax incentive.

Planet Innovation-backed company, Visus Therapeutics, raises US$36 million

PI's business model has been proven a success with another of its investee companies – Visus Therapeutics™ – raising $US36 ($A47) million in Series A financing.

Experienced medtech executive Sue MacLeman appointed to PI Board

Sue MacLeman, an experienced and respected leader in Australia’s medtech industry, has joined the Planet Innovation Board as a non-executive director.

Planet Innovation raises $9.8m in oversubscribed capital raise

Planet Innovation has closed an oversubscribed $9.8 million capital raising to accelerate business growth to meet strong international demand for its manufacturing, product development and digital services.

Global diagnostics leader Hany Massarany to join PI Board

Hany Massarany, a renowned leader in the global diagnostics industry, is joining the Planet Innovation Board as a non-executive director.

Industry leaders Jonathan Ling and Jim Fox join PI Board

PI has welcomed two experienced company leaders to the PI Board, with Jonathan Ling appointed Chairman and Jim Fox joining as a non-executive director.

Lumos Diagnostics and RPS Diagnostics merge

Lumos Diagnostics merges with RPS Diagnostics

Lumos Diagnostics and RPS Diagnostics have merged to create a full-service point-of-care diagnostic development company and support the international commercialization of FebriDx.

Silicon Valley star joins the Board of Planet Group

Planet Innovation has strengthened its position as a global player in the commercialisation of technology ventures with the strategic appointment of Teresa Engelhard to the Board of Planet Group Holdings.

PI launches new development and manufacturing center for medical and hi-tech products

At a formal ceremony attended by Australian Federal Assistant Treasurer, Josh Frydenberg, Planet Innovation (PI) has officially revealed its all new centre for Product Development and Manufacturing.